Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive impairments and the accumulation of pathological hallmarks, including amyloid-beta (Aβ) plaques and tau neurofibrillary tangles [2,3]. This evidence concerns the gene MAPT and Cognitive impairment.